Crossmark

Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study

Crossref DOI link: https://doi.org/10.1186/s12885-021-08082-2

Published Online: 2021-03-31

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Seo Ree

Hong, Ji Hyung

Sung, Soo-Yoon

Kim, Yeo Hyung

Chun, Sang Hoon

Lee, Hyun Woo

Lee, Jung Soo

Ko, Yoon Ho http://orcid.org/0000-0002-2506-3740
License Information

Text and Data Mining valid from 2021-03-31

Version of Record valid from 2021-03-31
More Information

Article History

Received: 13 July 2020

Accepted: 22 March 2021

First Online: 31 March 2021

Declarations

:

: This study was approved by the Institutional Review Board of the Uijeongbu St. Mary Hospital, College of Medicine, Catholic University of Korea [UC18ZESI0145], and it conforms to the provisions of the Helsinki Declaration, as revised in 2013 (available at: ExternalRef removed). The need for informed consent was waived because of the retrospective nature of the study.

: Not applicable.

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below